Author index
Volume 152 (2000)
www.elsevier.com/locate/atherosclerosis
Bo¨l, G.-F., see Brigelius-Flohe´, R. 152, 307
Bonardo, B., see Lopez, S. 152, 359 Bonavita, C.D., see Brites, F.D. 152, 181
Bots, M.L., see Westendorp, I.C.D. 152, 149
Boucher, B., see Mott, S. 152, 457
Bowman, B.A., see Freedman, D.S. 152, 441
Brigelius-Flohe´, R., S. Maurer, K. Lo¨tzer, G.-F. Bo¨l, H. Kallionpa¨a¨, P. Lehtolainen, H. Viita, S. Yla¨-Herttuala, Overexpression of PHGPx inhibits hydroperoxide-induced oxidation, NFkB activa-tion and apoptosis and affects oxLDL-mediated proliferaactiva-tion of rabbit aortic smooth muscle cells 152, 307
Brites, F.D., C.D. Bonavita, C. De Geitere, M. Cloe¨s, B. Delfly, M.J. Yael, J.-C. Fruchart, R.W. Wikinski, G.R. Castro, Alterations in the main steps of reverse cholesterol transport in male patients with primary hypertriglyceridemia and low HDL-cholesterol lev-els 152, 181
Bruschieri, L., see Denti, L. 152, 159
Buchmann, I., see Kotzerke, J. 152, 35
Byrne, C.D., see Halsall, D.J. 152, 9
Calabresi, L., see Sirtori, C.R. 152, 1
Calder, P.C., see Miles, E.A. 152, 43
Calleja, L., M.C. Trallero, C. Carrizosa, M.T. Me´ndez, E. Palacios-Alaiz, J. Osada, Effects of dietary fat amount and saturation on the regulation of hepatic mRNA and plasma apolipoprotein A-I in rats 152, 69
Candigliota, M., see Perticone, F. 152, 511
Carantoni, M., see Chen, N.G. 152, 203 Carrizosa, C., see Calleja, L. 152, 69 Castro, G.R., see Brites, F.D. 152, 181
Cecchetti, A., see Denti, L. 152, 159
Ceravolo, R., see Perticone, F. 152, 511
Chakko, S.C., see Lan Hsia, S. 152, 469
Chassereau, C., see Lopes-Virella, M.F. 152, 107
Chello, M., see Perticone, F. 152, 511
Chen, N.G., S. Azhar, F. Abbasi, M. Carantoni, G.M. Reaven, The relationship between plasma glucose and insulin responses to oral glucose, LDL oxidation, and soluble intercellular adhesion molecule-1 in healthy volunteers 152, 203
Chiba, H., see Yasuda, S. 152, 337
Chisholm, A., see Wallace, A.J. 152, 327
Chou, S.-C., see Teng, Y.-N. 152, 385 Cloe¨s, M., see Brites, F.D. 152, 181 Cloro, C., see Perticone, F. 152, 511
Coelingh Bennink, H.J.T., see Westendorp, I.C.D. 152, 149
Colletta, G., see Baccante, G. 152, 51
Coppa, A., see Baccante, G. 152, 51
Corella, D., C. Sa´iz, M. Guille´n, O. Portole´s, F. Mulet, J.I. Gonza´lez, J.M. Ordova´s, Association of TaqIB polymorphism in the cholesteryl ester transfer protein gene with plasma lipid levels in a healthy Spanish population 152, 367
Abbasi, F., see Chen, N.G. 152, 203
Ablondi, F., see Denti, L. 152, 159
Adler, Y., M. Vaturi, N. Fink, D. Tanne, Y. Shapira, D. Weisenberg, N. Sela, A. Sagie, Association between mitral annulus calcification and aortic atheroma: a prospective transesophageal echocardio-graphic study 152, 451
Adlouni, A., M. El Messal, R. Saı¨le, H.-J. Parra, J.-C. Fruchart, N. Ghalim, Probucol promotes reverse cholesterol transport in het-erozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles 152, 433
Aguilar-Salinas, C.A., F.J. Go´mez-Pe´rez, C. Posadas-Romero, C. Va´zquez-Cha´vez, E. Meaney, A. Gulı´as-Herrero, L.E. Guille´n, A. Alvarado Vega, E. Mendoza Pe´rez, L. Eduardo Romero-Nava, R. Ange´lica Go´mez-Dı´az, S. Salinas-Orozco, R. Moguel, G. Novoa, Efficacy and safety of atorvastatin in hyperlipidemic, type 2 dia-betic patients. A 34-week, multicenter, open-label study 152, 489 Akishita, M., see Ishikawa, M. 152, 97
Akita, H., see Rikitake, Y. 152, 79
Alvarado Vega, A., see Aguilar-Salinas, C.A. 152, 489
Amiral, J., see Blann, A.D. 152, 29
Amouyel, P., see Luc, G. 152, 399
Anami, Y., see Takemura, T. 152, 347
Ange´lica Go´mez-Dı´az, R., see Aguilar-Salinas, C.A. 152, 489
Angelucci, D., see Baccante, G. 152, 51
Argimon, J.M., see Salazar, A. 152, 497
Arveiler, D., see Luc, G. 152, 399
Aston, C.E., see Kamboh, M.I. 152, 193
Atsumi, T., see Yasuda, S. 152, 337
Aviv, A., see Okuda, K. 152, 391
Aviv, H., see Okuda, K. 152, 391 Azhar, S., see Chen, N.G. 152, 203
Baccante, G., G. Mincione, C. Di Febbo, A. Coppa, D. Angelucci, D. Lapenna, F. Cuccurullo, G. Colletta, E. Porreca, Increased type II transforming growth factor-breceptor expression in liver cells during cholesterol challenge 152, 51
Bai, H.-z., see Yamakawa, T. 152, 287
Bak, A.A.A., see Westendorp, I.C.D. 152, 149
Baraona, E., see Navder, K.P. 152, 89 Bard, J.-M., see Luc, G. 152, 399 Baur, R., see Kotzerke, J. 152, 35 Beisiegel, U., see Schiele, F. 152, 475 Belcaro, G., see Leng, G.C. 152, 167
Benditt, E.P., see O’Brien, E.R. 152, 117
Benedetti, R., see Denti, L. 152, 159
Berenson, G.S., see Freedman, D.S. 152, 441
Bethell, H., see Li, C.G. 152, 249
Bhatnagar, D., see Li, C.G. 152, 249
Biwa, T., see Takemura, T. 152, 347
Blann, A.D., J. Amiral, C.N. McCollum, G.Y.H. Lip, Differences in free and total tissue factor pathway inhibitor, and tissue factor in peripheral artery disease compared to healthy controls 152, 29
Cortellini, P., see Denti, L. 152, 159
Cuccurullo, F., see Baccante, G. 152, 51
De Backer, G., see Schiele, F. 152, 475
De Bacquer, D., see Schiele, F. 152, 475
deBono, D.P., see Salame, M.Y. 152, 19
De Geitere, C., see Brites, F.D. 152, 181
de Kleijn, M.J.J., see Westendorp, I.C.D. 152, 149
Delfly, B., see Brites, F.D. 152, 181
Demacker, P.N.M., see Kroon, A.A. 152, 519
de Man, F.H., R. Nieuwland, A. van der Laarse, F. Romijn, A.H.M. Smelt, J.A. Gevers Leuven, A. Sturk, Activated platelets in patients with severe hypertriglyceridemia: effects of triglyceride-lowering therapy 152, 407
Denti, L., G. Pasolini, P. Cortellini, L. Sanfelici, R. Benedetti, A. Cecchetti, S. Ferretti, L. Bruschieri, F. Ablondi, G. Valenti, Changes in HDL-cholesterol and lipoprotein Lp(a) after 6-month treatment with finasteride in males affected by benign prostatic hyperplasia (BPH) 152, 159
Dhanjil, S., see Leng, G.C. 152, 167
Di Febbo, C., see Baccante, G. 152, 51
Ducimetiere, P., see Luc, G. 152, 399 Duncan, R., see Lan Hsia, S. 152, 469
Duvillard, L., F. Pont, E. Florentin, P. Gambert, B. Verge`s, Ineffi-ciency of insulin therapy to correct apolipoprotein A-I metabolic abnormalities in non-insulin-dependent diabetes mellitus 152, 229 Ea-Kim, L., see Ghanam, K. 152, 59
Ebrahim, S., see Leng, G.C. 152, 167 Eden, J.A., see Howes, J.B. 152, 143
Eduardo Romero-Nava, L., see Aguilar-Salinas, C.A. 152, 489 Ehnholm, C., see Schiele, F. 152, 475
Ehnholm, C., see Tahvanainen, E. 152, 317 Ehnholm, C., see Tammi, A. 152, 135 El Messal, M., see Adlouni, A. 152, 433 Enockson, C., see Lopes-Virella, M.F. 152, 107 Evans, A., see Luc, G. 152, 399
Evans, A., see Schiele, F. 152, 475
Farinaro, E., see Tahvanainen, E. 152, 317
Ferretti, S., see Denti, L. 152, 159
Fink, N., see Adler, Y. 152, 451
Fiol, C., see Salazar, A. 152, 497
Fitzgerald, P.J., see Jeremias, A. 152, 209
Florentin, E., see Duvillard, L. 152, 229
Freedman, D.S., B.A. Bowman, J.D. Otvos, S.R. Srinivasan, G.S. Berenson, Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study 152, 441
Friedlander, Y., E. Leitersdorf, R. Vecsler, H. Funke, J. Kark, The contribution of candidate genes to the response of plasma lipids and lipoproteins to dietary challenge 152, 239
Fruchart, J.-C., see Adlouni, A. 152, 433
Fruchart, J.-C., see Brites, F.D. 152, 181
Funke, H., see Friedlander, Y. 152, 239
Gallippi, P., see Renner, W. 152, 175
Gambert, P., see Duvillard, L. 152, 229
Gardemann, A., M. Philipp, K. Heß, N. Katz, H. Tillmanns, W. Haberbosch, The paraoxonase Leu – Met54 and Gln – Arg191 gene polymorphisms are not associated with the risk of coronary heart disease 152, 421
Garvin, M.R., see O’Brien, E.R. 152, 117
Genest, J., Jr, see Mott, S. 152, 457
Gertler, R., see Kotzerke, J. 152, 35
Gevers Leuven, J.A., see de Man, F.H. 152, 407
Ghalim, N., see Adlouni, A. 152, 433
Ghanam, K., L. Ea-Kim, J. Javellaud, N. Oudart, Involvement of
potassium channels in the protective effect of 17b-estradiol on hypercholesterolemic rabbit carotid artery 152, 59
Go´mez-Pe´rez, F.J., see Aguilar-Salinas, C.A. 152, 489
Gonza´lez, J.I., see Corella, D. 152, 367
Gonza´lez, L., see Romero, F. 152, 127
Griffin, M., see Leng, G.C. 152, 167
Grobbee, D.E., see Westendorp, I.C.D. 152, 149
Gudnason, V., see Wallace, A.J. 152, 327
Guille´n, L.E., see Aguilar-Salinas, C.A. 152, 489
Guille´n, M., see Corella, D. 152, 367
Gulı´as-Herrero, A., see Aguilar-Salinas, C.A. 152, 489
Gylling, H., see Relas, H. 152, 377
Haberbosch, W., see Gardemann, A. 152, 421
Hales, C.N., see Halsall, D.J. 152, 9
Halsall, D.J., N.D. Martensz, J. Luan, P. Maison, N.J. Wareham, C.N. Hales, C.D. Byrne, A common apolipoprotein B signal peptide polymorphism modifies the relation between plasma non-esterified fatty acids and triglyceride concentration in men 152, 9 Hamman, R.F., see Kamboh, M.I. 152, 193
Hassan, A., see Jeremias, A. 152, 209 He, J.L., see Lan Hsia, S. 152, 469 Heß, K., see Gardemann, A. 152, 421 Hinohara, T., see O’Brien, E.R. 152, 117 Hirano, K.-i., see Yamashita, S. 152, 271 Hirata, K.-i., see Rikitake, Y. 152, 79 Hofman, A., see Westendorp, I.C.D. 152, 149 Hombach, V., see Kotzerke, J. 152, 35 Horita, T., see Yasuda, S. 152, 337 Horne, D., see Lopes-Virella, M.F. 152, 107
Howes, J.B., D. Sullivan, N. Lai, P. Nestel, S. Pomeroy, L. West, J.A. Eden, L.G. Howes, The effects of dietary supplementation with isoflavones from red clover on the lipoprotein profiles of post menopausal women with mild to moderate hypercholestero-laemia 152, 143
Howes, L.G., see Howes, J.B. 152, 143
Huang, J., see Knapp, A.C. 152, 217
Huegel, H., see Jeremias, A. 152, 209
Humphries, S.E., see Wallace, A.J. 152, 327
Hurtado, I., see Salazar, A. 152, 497
Ichikawa, K., see Yasuda, S. 152, 337
Inoue, N., see Rikitake, Y. 152, 79
Ishikawa, M., M. Akishita, K. Kozaki, K. Toba, A. Namiki, T. Yamaguchi, H. Orimo, Y. Ouchi, Expression of parathyroid hor-mone-related protein in human and experimental atherosclerotic lesions: functional role in arterial intimal thickening 152, 97
Javellaud, J., see Ghanam, K. 152, 59
Jeremias, A., H. Huegel, D.P. Lee, A. Hassan, A. Wolf, A.C. Yeung, P.G. Yock, P.J. Fitzgerald, Spatial orientation of atherosclerotic plaque in non-branching coronary artery segments 152, 209
Jokela, H., see Sillanaukee, P. 152, 503
Jokinen, E., see Tammi, A. 152, 135
Juhan-Vague, I., see Lopez, S. 152, 359
Kafatos, A., see Schiele, F. 152, 475
Kallionpa¨a¨, H., see Brigelius-Flohe´, R. 152, 307
Kamboh, M.I., C.E. Aston, R.F. Hamman, DNA sequence variation in human apolipoprotein C4 gene and its effect on plasma lipid profile 152, 193
Kark, J., see Friedlander, Y. 152, 239
Katz, N., see Gardemann, A. 152, 421
Kawai, Y., see Rikitake, Y. 152, 79
Kawashima, S., see Rikitake, Y. 152, 79
Khan, M.Y., see Okuda, K. 152, 391
Kimura, M., see Okuda, K. 152, 391
Kimura, Y., see Tani, T. 152, 299
Klein, R., see Lopes-Virella, M.F. 152, 107
Knapp, A.C., J. Huang, G. Starling, P.A. Kiener, Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death 152, 217
Koike, T., see Yasuda, S. 152, 337
Koivula, T., see Sillanaukee, P. 152, 503
Koskinen, S., see Lopes-Virella, M.F. 152, 107
Kotzerke, J., R. Gertler, I. Buchmann, R. Baur, V. Hombach, S. Norbert Reske, R. Voisard, Different radiosensitivity of smooth muscle cells and endothelial cells in vitro as demonstrated by irradiation from a Re-188 filled balloon catheter 152, 35
Kozaki, K., see Ishikawa, M. 152, 97
Krauss, C., see Renner, W. 152, 175
Kroon, A.A., M.A. van’t Hof, P.N.M. Demacker, A.F.H. Stalenhoef, The rebound of lipoproteins after LDL-apheresis. Kinetics and estimation of mean lipoprotein levels 152, 519
Kumar, S., see Li, C.G. 152, 249
Lai, N., see Howes, J.B. 152, 143
Lan Hsia, S., R. Duncan, A.H. Schob, S.C. Chakko, R. Mulingta-pang, J.L. He, G.O. Perez, Serum levels of high-density lipoprotein phospholipids correlate inversely with severity of angiographically defined coronary artery disease 152, 469
Lapenna, D., see Baccante, G. 152, 51 Lapinleimu, H., see Tammi, A. 152, 135 Lee-Chen, G.-J., see Teng, Y.-N. 152, 385 Lee, D.P., see Jeremias, A. 152, 209
Lehtolainen, P., see Brigelius-Flohe´, R. 152, 307 Leitersdorf, E., see Friedlander, Y. 152, 239
Leng, G.C., O. Papacosta, P. Whincup, G. Wannamethee, M. Walker, S. Ebrahim, A.N. Nicolaides, S. Dhanjil, M. Griffin, G. Belcaro, A. Rumley, G.D.O. Lowe, Femoral atherosclerosis in an older British population: prevalence and risk factors 152, 167 Li, C.G., H. Bethell, P.B. Wilson, D. Bhatnagar, M.G. Walker, S.
Kumar, The significance of CD105, TGFb and CD105/TGFb
complexes in coronary artery disease 152, 249
Lieber, C.S., see Navder, K.P. 152, 89
Lip, G.Y.H., see Blann, A.D. 152, 29
Lopes-Virella, M.F., S. Koskinen, M. Mironova, D. Horne, R. Klein, C. Chassereau, C. Enockson, G. Virella, The preparation of cop-per-oxidized LDL for the measurement of oxidized LDL antibodies by EIA 152, 107
Lopez, S., F. Peiretti, B. Bonardo, I. Juhan-Vague, G. Nalbone, Effect of atorvastatin and fluvastatin on the expression of plasmi-nogen activator inhibitor type-1 in cultured human endothelial cells 152, 359
Lo¨tzer, K., see Brigelius-Flohe´, R. 152, 307
Lowe, G.D.O., see Leng, G.C. 152, 167
Luan, J., see Halsall, D.J. 152, 9
Luc, G., J.-M. Bard, A. Evans, D. Arveiler, J.-B. Ruidavets, P. Amouyel, P. Ducimetiere, The relationship between apolipoprotein AI-containing lipoprotein fractions and environmental factors: the prospective epidemiological study of myocardial infarction (PRIME study) 152, 399
Maio, R., see Perticone, F. 152, 511
Maison, P., see Halsall, D.J. 152, 9
Man˜a, J., see Salazar, A. 152, 497
Mann, J.I., see Wallace, A.J. 152, 327
Marchioli, R., see Sirtori, C.R. 152, 1
Marcil, M., see Mott, S. 152, 457
Martensz, N.D., see Halsall, D.J. 152, 9
Martins, M.C., see Schiele, F. 152, 475
Marukawa, K., see Tani, T. 152, 299
Maruyama, T., see Yamashita, S. 152, 271
Masana, L., see Tahvanainen, E. 152, 317
Masood, I., see Salame, M.Y. 152, 19
Mastroroberto, P., see Perticone, F. 152, 511
Masuda, J., see Yamakawa, T. 152, 287
Matsuda, H., see Takemura, T. 152, 347
Matsuda, H., see Yamakawa, T. 152, 287
Matsumoto, K., S. Miyake, M. Yano, Y. Ueki, Y. Tominaga, High serum concentrations of soluble E-selectin in patients with impaired glucose tolerance with hyperinsulinemia 152, 415
Matsumura, T., see Takemura, T. 152, 347
Matsuura, E., see Yasuda, S. 152, 337
Matsuzawa, Y., see Yamashita, S. 152, 271
Mattioli, P.L., see Perticone, F. 152, 511
Maurer, S., see Brigelius-Flohe´, R. 152, 307
McCollum, C.N., see Blann, A.D. 152, 29
Meaney, E., see Aguilar-Salinas, C.A. 152, 489 Me´ndez, M.T., see Calleja, L. 152, 69
Mendoza Pe´rez, E., see Aguilar-Salinas, C.A. 152, 489 Miettinen, T.A., see Relas, H. 152, 377
Miles, E.A., F.A. Wallace, P.C. Calder, Dietary fish oil reduces intercellular adhesion molecule 1 and scavenger receptor expression on murine macrophages 152, 43
Mincione, G., see Baccante, G. 152, 51 Mironova, M., see Lopes-Virella, M.F. 152, 107 Miyake, S., see Matsumoto, K. 152, 415 Miyoshi, Y., see Yasuda, S. 152, 337
Moguel, R., see Aguilar-Salinas, C.A. 152, 489 Molin, M., see Tahvanainen, E. 152, 317 Mongiardo, A., see Perticone, F. 152, 511
Mott, S., L. Yu, M. Marcil, B. Boucher, C. Rondeau, J. Genest, Jr, Decreased cellular cholesterol efflux is a common cause of familial hypoalphalipoproteinemia: role of the ABCA1 gene muta-tions 152, 457
Mulet, F., see Corella, D. 152, 367
Mulingtapang, R., see Lan Hsia, S. 152, 469
Nakagawa, Y., see Rikitake, Y. 152, 79
Nakajima, N., see Yamashita, S. 152, 271
Nalbone, G., see Lopez, S. 152, 359
Namiki, A., see Ishikawa, M. 152, 97
Navder, K.P., E. Baraona, C.S. Lieber, Dilinoleoylphosphatidyl-choline protects human low density lipoproteins against oxida-tion 152, 89
Nestel, P., see Howes, J.B. 152, 143
Nicaud, V., see Tahvanainen, E. 152, 317
Nicolaides, A.N., see Leng, G.C. 152, 167
Nieuwland, R., see de Man, F.H. 152, 407
Nishikawa, T., see Takemura, T. 152, 347
Norbert Reske, S., see Kotzerke, J. 152, 35
Novoa, G., see Aguilar-Salinas, C.A. 152, 489
O’Brien, E.R., S. Urieli-Shoval, M.R. Garvin, D.K. Stewart, T. Hinohara, J.B. Simpson, E.P. Benditt, S.M. Schwartz, Replication in restenotic atherectomy tissue 152, 117
Ogata, J., see Yamakawa, T. 152, 287
Okuda, K., M.Y. Khan, J. Skurnick, M. Kimura, H. Aviv, A. Aviv, Telomere attrition of the human abdominal aorta: relationships with age and atherosclerosis 152, 391
Ordova´s, J.M., see Corella, D. 152, 367
Orimo, H., see Ishikawa, M. 152, 97
Osada, J., see Calleja, L. 152, 69
Otvos, J.D., see Freedman, D.S. 152, 441
Ouchi, Y., see Ishikawa, M. 152, 97
Oudart, N., see Ghanam, K. 152, 59
Palacios-Alaiz, E., see Calleja, L. 152, 69
Papacosta, O., see Leng, G.C. 152, 167
Parra, G., see Romero, F. 152, 127
Parra, H.-J., see Adlouni, A. 152, 433
Pasolini, G., see Denti, L. 152, 159
Peiretti, F., see Lopez, S. 152, 359
Perez, G.O., see Lan Hsia, S. 152, 469
Perticone, F., R. Ceravolo, R. Maio, C. Cloro, M. Candigliota, A. Scozzafava, A. Mongiardo, P. Mastroroberto, M. Chello, P.L. Mattioli, Effects of atorvastatin and vitamin C on endothelial function of hypercholesterolemic patients 152, 511
Philipp, M., see Gardemann, A. 152, 421 Pilger, E., see Renner, W. 152, 175
Pinto, X., see Salazar, A. 152, 497
Pitka¨ja¨rvi, T., see Sillanaukee, P. 152, 503
Planellas, J., see Westendorp, I.C.D. 152, 149
Pomeroy, S., see Howes, J.B. 152, 143
Pons, H., see Romero, F. 152, 127
Pont, F., see Duvillard, L. 152, 229
Porreca, E., see Baccante, G. 152, 51
Portole´s, O., see Corella, D. 152, 367
Posadas-Romero, C., see Aguilar-Salinas, C.A. 152, 489
Pujol, R., see Salazar, A. 152, 497
Quiroz, Y., see Romero, F. 152, 127 Reaven, G.M., see Chen, N.G. 152, 203
Relas, H., H. Gylling, T.A. Miettinen, Dietary squalene increases cholesterol synthesis measured with serum non-cholesterol sterols after a single oral dose in humans 152, 377
Renner, W., K. Schallmoser, P. Gallippi, C. Krauss, H. Toplak, T.C. Wascher, E. Pilger, C242T polymorphism of the p22 phox gene is not associated with peripheral arterial occlusive disease 152, 175
Rikitake, Y., K.-i. Hirata, S. Kawashima, N. Inoue, H. Akita, Y. Kawai, Y. Nakagawa, M. Yokoyama, Inhibition of endothelium-dependent arterial relaxation by oxidized phosphatidyl-choline 152, 79
Rinco´n, J., see Romero, F. 152, 127
Rodrı´guez-Iturbe, B., see Romero, F. 152, 127
Romero, F., B. Rodrı´guez-Iturbe, H. Pons, G. Parra, Y. Quiroz, J. Rinco´n, L. Gonza´lez, Mycophenolate mofetil treatment reduces cholesterol-induced atherosclerosis in the rabbit 152, 127 Romijn, F., see de Man, F.H. 152, 407
Rondeau, C., see Mott, S. 152, 457 Ro¨nnemaa, T., see Tammi, A. 152, 135 Rubins, H.B., see Sirtori, C.R. 152, 1
Ruidavets, J.-B., see Luc, G. 152, 399
Rumley, A., see Leng, G.C. 152, 167
Sagie, A., see Adler, Y. 152, 451
Sa´iz, C., see Corella, D. 152, 367
Sakai, M., see Takemura, T. 152, 347
Sakai, N., see Yamashita, S. 152, 271
Salame, M.Y., N.J. Samani, I. Masood, D.P. deBono, Expression of the plasminogen activator system in the human vascular wall 152,
19
Salazar, A., J. Man˜a, C. Fiol, I. Hurtado, J.M. Argimon, R. Pujol, X. Pinto, Influence of serum amyloid A on the decrease of high density lipoprotein-cholesterol in active sarcoidosis 152, 497 Saı¨le, R., see Adlouni, A. 152, 433
Salinas-Orozco, S., see Aguilar-Salinas, C.A. 152, 489 Samani, N.J., see Salame, M.Y. 152, 19
Sanfelici, L., see Denti, L. 152, 159
Sans, S., see Schiele, F. 152, 475
Sasahara, T., see Takemura, T. 152, 347
Sass, C., see Schiele, F. 152, 475
Sawa, Y., see Yamakawa, T. 152, 287
Schallmoser, K., see Renner, W. 152, 175
Schiele, F., D. De Bacquer, M. Vincent-Viry, U. Beisiegel, C. Ehn-holm, A. Evans, A. Kafatos, M.C. Martins, S. Sans, C. Sass, S. Visvikis, G. De Backer, G. Siest, Apolipoprotein E serum concen-tration and polymorphism in six European countries: the ApoEurope Project 152, 475
Schob, A.H., see Lan Hsia, S. 152, 469 Schwartz, S.M., see O’Brien, E.R. 152, 117 Scozzafava, A., see Perticone, F. 152, 511 Sela, N., see Adler, Y. 152, 451
Seppa¨, K., see Sillanaukee, P. 152, 503
Shapira, Y., see Adler, Y. 152, 451
Shichiri, M., see Takemura, T. 152, 347
Shirakura, R., see Yamakawa, T. 152, 287
Siest, G., see Schiele, F. 152, 475
Sillanaukee, P., T. Koivula, H. Jokela, T. Pitka¨ja¨rvi, K. Seppa¨, Alcohol consumption and its relation to lipid-based cardiovascular risk factors among middle-aged women: the role of HDL3 choles-terol 152, 503
Simell, O., see Tammi, A. 152, 135
Simpson, J.B., see O’Brien, E.R. 152, 117
Sirtori, C.R., L. Calabresi, R. Marchioli, H.B. Rubins, Cardiovascu-lar risk changes after lipid lowering medications: are they pre-dictable? 152, 1
Skeaff, C.M., see Wallace, A.J. 152, 327 Skurnick, J., see Okuda, K. 152, 391 Smelt, A.H.M., see de Man, F.H. 152, 407
Srinivasan, S.R., see Freedman, D.S. 152, 441
Stalenhoef, A.F.H., see Kroon, A.A. 152, 519
Starling, G., see Knapp, A.C. 152, 217
Stewart, D.K., see O’Brien, E.R. 152, 117
Sturk, A., see de Man, F.H. 152, 407
Sudo, T., see Tani, T. 152, 299
Sullivan, D., see Howes, J.B. 152, 143
Sutherland, W.H.F., see Wallace, A.J. 152, 327
Tahvanainen, E., M. Molin, S. Vainio, L. Tiret, V. Nicaud, E. Farinaro, L. Masana, C. Ehnholm, Intestinal fatty acid binding protein polymorphism at codon 54 is not associated with postpran-dial responses to fat and glucose tolerance tests in healthy young Europeans. Results from EARS II participants 152, 317 Tai, D.-Y., see Teng, Y.-N. 152, 385
Takemura, T., M. Sakai, H. Matsuda, T. Matsumura, T. Biwa, Y. Anami, T. Nishikawa, T. Sasahara, M. Shichiri, Effects of probu-col on cholesterol metabolism in mouse peritoneal macrophages: inhibition of HDL-mediated cholesterol efflux 152, 347
Takeuchi, R., see Yasuda, S. 152, 337
Talmud, P.J., see Wallace, A.J. 152, 327
Tammi, A., T. Ro¨nnemaa, J. Viikari, E. Jokinen, H. Lapinleimu, C. Ehnholm, O. Simell, Apolipoprotein E4 phenotype increases non-fasting serum triglyceride concentration in infants — the STRIP study 152, 135
Tani, T., K. Uehara, T. Sudo, K. Marukawa, Y. Yasuda, Y. Kimura, Cilostazol, a selective type III phosphodiesterase inhibitor, de-creases triglyceride and inde-creases HDL cholesterol levels by increas-ing lipoprotein lipase activity in rats 152, 299
Tanne, D., see Adler, Y. 152, 451
Teng, Y.-N., J.-P. Pan, S.-C. Chou, D.-Y. Tai, G.-J. Lee-Chen, Familial defective apolipoprotein B-100: detection and haplotype analysis of the Arg3500Gln mutation in hyperlipidemic Chi-nese 152, 385
Tillmanns, H., see Gardemann, A. 152, 421
Tiret, L., see Tahvanainen, E. 152, 317
Toba, K., see Ishikawa, M. 152, 97
Tominaga, Y., see Matsumoto, K. 152, 415
Toplak, H., see Renner, W. 152, 175
Trallero, M.C., see Calleja, L. 152, 69
Uehara, K., see Tani, T. 152, 299
Ueki, Y., see Matsumoto, K. 152, 415
Urieli-Shoval, S., see O’Brien, E.R. 152, 117
Vainio, S., see Tahvanainen, E. 152, 317 Valenti, G., see Denti, L. 152, 159
van der Laarse, A., see de Man, F.H. 152, 407 van’t Hof, M.A., see Kroon, A.A. 152, 519 Vaturi, M., see Adler, Y. 152, 451
Va´zquez-Cha´vez, C., see Aguilar-Salinas, C.A. 152, 489
Vecsler, R., see Friedlander, Y. 152, 239
Verge`s, B., see Duvillard, L. 152, 229
Viikari, J., see Tammi, A. 152, 135
Viita, H., see Brigelius-Flohe´, R. 152, 307
Vincent-Viry, M., see Schiele, F. 152, 475
Virella, G., see Lopes-Virella, M.F. 152, 107
Visvikis, S., see Schiele, F. 152, 475
Voisard, R., see Kotzerke, J. 152, 35
Walker, M.G., see Li, C.G. 152, 249
Walker, M., see Leng, G.C. 152, 167
Wallace, A.J., J.I. Mann, W.H.F. Sutherland, S. Williams, A. Chisholm, C.M. Skeaff, V. Gudnason, P.J. Talmud, S.E. Humphries, Variants in the cholesterol ester transfer protein and lipoprotein lipase genes are predictors of plasma cholesterol re-sponse to dietary change 152, 327
Wallace, F.A., see Miles, E.A. 152, 43
Wannamethee, G., see Leng, G.C. 152, 167
Wareham, N.J., see Halsall, D.J. 152, 9
Wascher, T.C., see Renner, W. 152, 175
Weisenberg, D., see Adler, Y. 152, 451
Westendorp, I.C.D., M.J.J. de Kleijn, M.L. Bots, A.A.A. Bak, J. Planellas, H.J.T. Coelingh Bennink, A. Hofman, D.E. Grobbee,
J.C.M. Witteman, The effect of hormone replacement therapy on arterial distensibility and compliance in perimenopausal women: a 2-year randomised trial 152, 149
West, L., see Howes, J.B. 152, 143
Whincup, P., see Leng, G.C. 152, 167 Wikinski, R.W., see Brites, F.D. 152, 181 Williams, S., see Wallace, A.J. 152, 327 Wilson, P.B., see Li, C.G. 152, 249
Witteman, J.C.M., see Westendorp, I.C.D. 152, 149 Wolf, A., see Jeremias, A. 152, 209
Yael, M.J., see Brites, F.D. 152, 181
Yamaguchi, T., see Ishikawa, M. 152, 97
Yamakawa, T., H.-z. Bai, J. Masuda, Y. Sawa, R. Shirakura, J. Ogata, H. Matsuda, Differential expression of proteoglycans bigly-can and decorin during neointima formation after stent implanta-tion in normal and atherosclerotic rabbit aortas 152, 287
Yamashita, S., T. Maruyama, K.-i. Hirano, N. Sakai, N. Nakajima, Y. Matsuzawa, Molecular mechanisms, lipoprotein abnormalities and atherogenicity of hyperalphalipoproteinemia 152, 271
Yanai, H., see Yasuda, S. 152, 337
Yano, M., see Matsumoto, K. 152, 415
Yasuda, S., A. Tsutsumi, H. Chiba, H. Yanai, Y. Miyoshi, R. Takeuchi, T. Horita, T. Atsumi, K. Ichikawa, E. Matsuura, T. Koike,b2-glycoprotein I deficiency: prevalence, genetic background and effects on plasma lipoprotein metabolism and hemosta-sis 152, 337
Yasuda, Y., see Tani, T. 152, 299
Yeung, A.C., see Jeremias, A. 152, 209
Yla¨-Herttuala, S., see Brigelius-Flohe´, R. 152, 307
Yock, P.G., see Jeremias, A. 152, 209
Yokoyama, M., see Rikitake, Y. 152, 79
